The retinoid x receptor agonist bexarotene relieves positive symptoms of schizophrenia: A 6-week, randomized, double-blind, placebo-controlled multicenter trial
Vladimir Lerner, Chanoch Miodownik, Anatoly Gibel, Pinchas Sirota, Ilan Bush, Hadi Elliot, Ruben Benatov, Michael S. Ritsner*
Research output: Contribution to journal › Article › peer-review
42Scopus
citations
Fingerprint
Dive into the research topics of 'The retinoid x receptor agonist bexarotene relieves positive symptoms of schizophrenia: A 6-week, randomized, double-blind, placebo-controlled multicenter trial'. Together they form a unique fingerprint.